1. Home
  2. DPRO vs CTXR Comparison

DPRO vs CTXR Comparison

Compare DPRO & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DPRO
  • CTXR
  • Stock Information
  • Founded
  • DPRO 1998
  • CTXR 2007
  • Country
  • DPRO Canada
  • CTXR United States
  • Employees
  • DPRO N/A
  • CTXR N/A
  • Industry
  • DPRO Aerospace
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • DPRO Industrials
  • CTXR Health Care
  • Exchange
  • DPRO Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • DPRO 15.3M
  • CTXR 14.6M
  • IPO Year
  • DPRO N/A
  • CTXR N/A
  • Fundamental
  • Price
  • DPRO $1.89
  • CTXR $0.70
  • Analyst Decision
  • DPRO Strong Buy
  • CTXR Strong Buy
  • Analyst Count
  • DPRO 2
  • CTXR 2
  • Target Price
  • DPRO $7.00
  • CTXR N/A
  • AVG Volume (30 Days)
  • DPRO 205.8K
  • CTXR 145.1K
  • Earning Date
  • DPRO 05-20-2025
  • CTXR 05-16-2025
  • Dividend Yield
  • DPRO N/A
  • CTXR N/A
  • EPS Growth
  • DPRO N/A
  • CTXR N/A
  • EPS
  • DPRO N/A
  • CTXR N/A
  • Revenue
  • DPRO $4,559,961.00
  • CTXR N/A
  • Revenue This Year
  • DPRO $94.01
  • CTXR N/A
  • Revenue Next Year
  • DPRO $95.14
  • CTXR N/A
  • P/E Ratio
  • DPRO N/A
  • CTXR N/A
  • Revenue Growth
  • DPRO 0.10
  • CTXR N/A
  • 52 Week Low
  • DPRO $1.55
  • CTXR $0.68
  • 52 Week High
  • DPRO $9.13
  • CTXR $26.25
  • Technical
  • Relative Strength Index (RSI)
  • DPRO 35.44
  • CTXR 29.57
  • Support Level
  • DPRO $1.67
  • CTXR $0.68
  • Resistance Level
  • DPRO $1.98
  • CTXR $0.82
  • Average True Range (ATR)
  • DPRO 0.18
  • CTXR 0.09
  • MACD
  • DPRO -0.09
  • CTXR 0.02
  • Stochastic Oscillator
  • DPRO 17.19
  • CTXR 16.12

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: